Dimed S.A. Distribuidora de Medicamentos (PNVL3.SA)
BRL 9.03
(-1.63%)
BRL 9.03
(-1.63%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 166.57 Million BRL | -4.06% |
| 2022 | 149.01 Million BRL | 22.52% |
| 2021 | 121.61 Million BRL | 56.2% |
| 2020 | 77.85 Million BRL | -33.46% |
| 2019 | 117 Million BRL | 4.83% |
| 2018 | 111.61 Million BRL | 7.04% |
| 2017 | 104.27 Million BRL | -0.59% |
| 2016 | 104.89 Million BRL | 69.18% |
| 2015 | 62 Million BRL | 0.8% |
| 2014 | 61.51 Million BRL | -13.73% |
| 2013 | 71.29 Million BRL | -10.12% |
| 2012 | 79.32 Million BRL | 53.82% |
| 2011 | 51.56 Million BRL | -3.82% |
| 2010 | 53.61 Million BRL | 11.52% |
| 2009 | 48.07 Million BRL | 372.79% |
| 2008 | 10.16 Million BRL | -42.12% |
| 2007 | 17.56 Million BRL | -5.83% |
| 2006 | 18.65 Million BRL | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 49.84 Million BRL | 56.47% |
| 2024 Q2 | 25.48 Million BRL | -48.87% |
| 2023 Q4 | 31.85 Million BRL | -42.49% |
| 2023 FY | 142.96 Million BRL | -4.06% |
| 2023 Q3 | 55.38 Million BRL | 13.94% |
| 2023 Q1 | 41.98 Million BRL | 7.44% |
| 2023 Q2 | 48.61 Million BRL | 15.78% |
| 2022 Q3 | 40.85 Million BRL | -7.74% |
| 2022 FY | 149.01 Million BRL | 22.52% |
| 2022 Q2 | 44.28 Million BRL | 61.18% |
| 2022 Q4 | 39.08 Million BRL | -4.34% |
| 2022 Q1 | 27.47 Million BRL | -6.62% |
| 2021 Q3 | 24.54 Million BRL | -5.44% |
| 2021 FY | 121.61 Million BRL | 56.2% |
| 2021 Q1 | 25.62 Million BRL | -8.15% |
| 2021 Q2 | 25.95 Million BRL | 1.27% |
| 2021 Q4 | 29.42 Million BRL | 19.88% |
| 2020 Q1 | 28.69 Million BRL | -14.77% |
| 2020 FY | 77.85 Million BRL | -33.46% |
| 2020 Q2 | 12.29 Million BRL | -57.15% |
| 2020 Q3 | 25.09 Million BRL | 104.07% |
| 2020 Q4 | 27.9 Million BRL | 11.21% |
| 2019 Q3 | 35.41 Million BRL | 6.02% |
| 2019 Q4 | 33.66 Million BRL | -4.92% |
| 2019 FY | 117 Million BRL | 4.83% |
| 2019 Q1 | 24.2 Million BRL | -23.26% |
| 2019 Q2 | 33.4 Million BRL | 37.98% |
| 2018 Q3 | 184.42 Million BRL | 602.72% |
| 2018 Q4 | 31.54 Million BRL | -82.9% |
| 2018 Q2 | 26.24 Million BRL | 31.94% |
| 2018 Q1 | 19.89 Million BRL | -27.06% |
| 2018 FY | 111.61 Million BRL | 7.04% |
| 2017 Q4 | 27.27 Million BRL | 12.56% |
| 2017 Q1 | 25.29 Million BRL | -29.59% |
| 2017 Q2 | 27.47 Million BRL | 8.61% |
| 2017 FY | 104.27 Million BRL | -0.59% |
| 2017 Q3 | 24.22 Million BRL | -11.82% |
| 2016 FY | 104.89 Million BRL | 69.18% |
| 2016 Q4 | 35.93 Million BRL | 51.29% |
| 2016 Q3 | 23.75 Million BRL | -18.75% |
| 2016 Q2 | 29.23 Million BRL | 40.37% |
| 2016 Q1 | 20.82 Million BRL | 1128.67% |
| 2015 Q2 | 24.11 Million BRL | 84.5% |
| 2015 FY | 62 Million BRL | 0.8% |
| 2015 Q3 | 23.11 Million BRL | -4.13% |
| 2015 Q4 | 1.69 Million BRL | -92.67% |
| 2015 Q1 | 13.07 Million BRL | 81.64% |
| 2014 Q3 | 17.95 Million BRL | -20.15% |
| 2014 Q1 | 13.88 Million BRL | 130.01% |
| 2014 FY | 61.51 Million BRL | -13.73% |
| 2014 Q4 | 7.19 Million BRL | -59.91% |
| 2014 Q2 | 22.48 Million BRL | 61.96% |
| 2013 Q1 | 14.4 Million BRL | -43.4% |
| 2013 FY | 71.29 Million BRL | -10.12% |
| 2013 Q4 | 6.03 Million BRL | -77.9% |
| 2013 Q3 | 27.3 Million BRL | 15.88% |
| 2013 Q2 | 23.56 Million BRL | 63.59% |
| 2012 FY | 79.32 Million BRL | 53.82% |
| 2012 Q3 | 19.89 Million BRL | 0.0% |
| 2012 Q4 | 25.44 Million BRL | 27.86% |
| 2011 FY | 51.56 Million BRL | -3.82% |
| 2010 FY | 53.61 Million BRL | 11.52% |
| 2009 FY | 48.07 Million BRL | 372.79% |
| 2008 FY | 10.16 Million BRL | -42.12% |
| 2007 FY | 17.56 Million BRL | -5.83% |
| 2006 FY | 18.65 Million BRL | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|